Author

Kyle Tran

University of California Davis Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Anna Y. YotovaiD· 1 shared Emily Z. HuieiD· 1 shared Emma R. Monsen· 1 shared Jill L. SilvermaniD· 1 shared John J MarshalliD· 1 shared Kim M. Hansen· 1 shared Mandar T. NaikiD· 1 shared Mengia S. Rioult-Pedotti· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Anna Y. YotovaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Peptidomimetic inhibitors targeting TrkB/PSD-95 signaling improves cognition and seizure outcomes in an Angelman Syndrome mouse model

Emily Z. Huie, Xin Yang, Mengia S. Rioult-Pedotti, Kyle Tran, Emma R. Monsen, Kim M. Hansen, Michelle A. Erickson, Mandar T. Naik, Anna Y. Yotova, William A. Banks, Yu‐Wen Alvin Huang, Jill L. Silverman, John J Marshall

The paper evaluates peptidomimetic inhibitors targeting TrkB/PSD-95 signaling in an Angelman Syndrome mouse model, showing improved seizure outcomes and cognition but not motor function.

Neuropsychopharmacology · Nov 7, 2024Peer-reviewedNeuroscience